CorMedix (CRMD) EBIAT (2016 - 2025)
Historic EBIAT for CorMedix (CRMD) over the last 14 years, with Q3 2025 value amounting to $108.6 million.
- CorMedix's EBIAT rose 400962.66% to $108.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $162.5 million, marking a year-over-year increase of 49500.26%. This contributed to the annual value of -$17.9 million for FY2024, which is 6130.7% up from last year.
- CorMedix's EBIAT amounted to $108.6 million in Q3 2025, which was up 400962.66% from $19.8 million recorded in Q2 2025.
- In the past 5 years, CorMedix's EBIAT ranged from a high of $108.6 million in Q3 2025 and a low of -$14.5 million during Q1 2024
- Over the past 5 years, CorMedix's median EBIAT value was -$7.4 million (recorded in 2021), while the average stood at $2.3 million.
- Its EBIAT has fluctuated over the past 5 years, first plummeted by 6414.73% in 2022, then soared by 400962.66% in 2025.
- Over the past 5 years, CorMedix's EBIAT (Quarter) stood at -$7.8 million in 2021, then fell by 5.36% to -$8.2 million in 2022, then dropped by 18.7% to -$9.7 million in 2023, then skyrocketed by 238.18% to $13.5 million in 2024, then soared by 706.3% to $108.6 million in 2025.
- Its EBIAT stands at $108.6 million for Q3 2025, versus $19.8 million for Q2 2025 and $20.6 million for Q1 2025.